<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180610040037N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-10-28</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of  Behavioral Self-Regulation Counseling on HIV Treatment Adherence Delivered by Phone</public_title>
      <acronym></acronym>
      <scientific_title>Effect of  Behavioral Self-Regulation Counseling on HIV Treatment Adherence Delivered by Phone</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/50054</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: In this study, because the sample size is 40 people, this amount is less than 100. If people are divided into 2 groups by simple random method. According to the law of tap and line randomization, the number of taps and lines may not be equal in the two groups. Therefore, the Block-Randomization method is used. The sample size calculated in this study is 40 people. Therefore, 10 blocks of 4 people are formed and 5 blocks are randomly assigned to each group. As a result, the balance between the two groups is assigned to one group of 20 people and the other 20 people to the second group. A simple random method is used to assign people to each block. This means that people are placed in one of these blocks based on a table of random numbers.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Human immunodeficiency virus.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:20 HIV-positive participants In the intervention group we hold 5 consultation sessions based on self- regulation.The time of each session is 45 minutes.                                                                       After being in the intervention group, it tests, which includes two questionnaires: the degree of adherence to treatment and increasing self-regulation skills in the individual, because if you want to do the treatment accurately and treat the person in the field of your skills, it will determine Be. After people have taken their antiretroviral drugs, they are asked to do so for 10 weeks (until their last telephone consultation) each day they buy their drugs to avoid the mobile number they are considering for the plan. Taken, send SMS. The number of unused pills of all participants is measured each week and recorded in the relevant form. After the last telephone counseling session for the intervention group, follow-up to adhere to the treatment for individuals for a period of two weeks - four weeks - and two months later by telephone with each participant. At the end, participants are assessed for their adherence to treatment and self-regulatory skills, and the pre-test and post-test results are compared. Intervention 2: Control group:20 people who are HIV-positive in the control group they will receive just routine voluntary and counseling protocol for HIV consultation. After placing the people in the control group, the pre-test, which includes two questionnaires, the amount of adherence to treatment and the level of self-regulatory skills in the person, is taken from them to determine the exact score of adherence to treatment and his total score in self-regulatory skills. After people receive their antiretroviral drugs, they are asked to immediately send a text message to the mobile number provided for the plan for 10 weeks each day they take their medication. The number of unused pills of all participants is measured each week and recorded in the relevant form.After the last telephone counseling session for the intervention group, follow-up to adhere to the treatment for individuals for a period of two weeks - four weeks - and two months later by telephone with each participant. At the end, participants are assessed for their adherence to treatment and self-regulatory skills, and the pre-test and post-test results are compared.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is No information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Seyd Ali Dehghan Menshadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The Department of Infectious and tropical Disease, Imam Khomeini Hospital, Keshavarz Blvd.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14-19-733141</zip>
        <telephone>+98 21 6119 2047</telephone>
        <email>a_dehghanm@sina.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Seyd Ali Dehghan Menshadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>The Department of Infectious and tropical Disease, Imam Khomeini Hospital, Keshavarz Blvd.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14-19-7331411</zip>
        <telephone>+98 21 6119 2047</telephone>
        <email>a_dehghanm@sinam.tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>People must be over 18 years old to participate in the project.
Participants must be HIV positive and have a folder and receive medication at the Behavioral Diseases Counseling Center of Imam Khomeini Hospital between 2016 and 2017.
The rate of adherence to drug therapy in participants should be less than 95%.
Participants should be know with how to use a cell phone and send text messages.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>People who are not satisfied with participating in this project.
People who, in addition to HIV, have a psychotic disorder and are taking psychiatric medication.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>B20</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Human immunodeficiency virus [HIV] disease</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:20 HIV-positive participants In the intervention group we hold 5 consultation sessions based on self- regulation.The time of each session is 45 minutes.                                                                       After being in the intervention group, it tests, which includes two questionnaires: the degree of adherence to treatment and increasing self-regulation skills in the individual, because if you want to do the treatment accurately and treat the person in the field of your skills, it will determine Be. After people have taken their antiretroviral drugs, they are asked to do so for 10 weeks (until their last telephone consultation) each day they buy their drugs to avoid the mobile number they are considering for the plan. Taken, send SMS. The number of unused pills of all participants is measured each week and recorded in the relevant form. After the last telephone counseling session for the intervention group, follow-up to adhere to the treatment for individuals for a period of two weeks - four weeks - and two months later by telephone with each participant. At the end, participants are assessed for their adherence to treatment and self-regulatory skills, and the pre-test and post-test results are compared.</i_keyword>
      <i_keyword>Control group:20 people who are HIV-positive in the control group they will receive just routine voluntary and counseling protocol for HIV consultation. After placing the people in the control group, the pre-test, which includes two questionnaires, the amount of adherence to treatment and the level of self-regulatory skills in the person, is taken from them to determine the exact score of adherence to treatment and his total score in self-regulatory skills. After people receive their antiretroviral drugs, they are asked to immediately send a text message to the mobile number provided for the plan for 10 weeks each day they take their medication. The number of unused pills of all participants is measured each week and recorded in the relevant form.After the last telephone counseling session for the intervention group, follow-up to adhere to the treatment for individuals for a period of two weeks - four weeks - and two months later by telephone with each participant. At the end, participants are assessed for their adherence to treatment and self-regulatory skills, and the pre-test and post-test results are compared.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adherence for Treatment. Timepoint: At the beginning of the study (before the intervention) at the end of the study and 2 weeks, 4 weeks and 2 months after the completion of the study. Method of measurement: Measure adherence to treatment based on self-report and include in the Adherence measurement formula.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Increase of self-regulation. Timepoint: At the beginning of the study (before the intervention) at the end of the study and 2 weeks, 4 weeks and 2 months after the completion of the study. Method of measurement: Self-Regulation questionnaire, this questionnaire was prepared by Miller &amp; Brown(1999) for measure self-regulating components.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-07-29</approval_date>
        <contact_name>Ethics Committee of Tehran University of Medical Sciences</contact_name>
        <contact_address>Central Office of Tehran University of Medical Sciences, Corner of Ghods Street, Keshavarz Blvd., Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
